Cure Today22h
Learning to Live with Advanced Non-Small Cell Lung Cancer
Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include: ...
Boehringer’s zongertinib receives Priority Review from U.S. FDA for the treatment of HER2 (ERBB2)-mutant advanced non-small cell lung cancer
Zongertinib would be the first orally administered, targeted therapy for previously treated patients with (NSCLC), if approved The application for this investigational treatment is based on positive ...
Targeted Oncology20h
FDA Fast-Tracks IBI363 in Squamous NSCLC
The FDA granted fast track status to IBI363 for the treatment of patients with advanced squamous lung cancer after prior ...
Five-second finger test may unveil an early stage lung cancer symptom - what to do
Experts suggest that a simple 'finger test' could help detect lung cancer early - potentially saving lives. While chest pain, ...
Simple 'finger test' to check for early signs of lung cancer in your hands
Lung cancer is one of the most common and serious types of cancer - and spotting the early signs could save your life.
Targeted Oncology1h
Use of RNA-Based Molecular Panels in Metastatic NSCLC
Panelists discuss the use of RNA-based molecular panels in metastatic non–-small cell lung cancer (NSCLC), highlighting their ...
manilatimes16h
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Updates
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address ...